Copyright Reports & Markets. All rights reserved.

Global H1N1 Vaccines Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 H1N1 Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key H1N1 Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global H1N1 Vaccines Market Size Growth Rate by Type
    • 1.4.2 Intramuscular Vaccines
    • 1.4.3 Intranasal Vaccines
    • 1.4.4 Intradermal Vaccines
  • 1.5 Market by Application
    • 1.5.1 Global H1N1 Vaccines Market Size Growth Rate by Application
    • 1.5.2 Influenza
    • 1.5.3 Meningococcal
    • 1.5.4 Cervical Cancer
    • 1.5.5 Pneumococcal
    • 1.5.6 Hepatitis
    • 1.5.7 Measles
    • 1.5.8 Mumps
    • 1.5.9 Rubella
    • 1.5.10 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global H1N1 Vaccines Market Size, Estimates and Forecasts
    • 2.1.1 Global H1N1 Vaccines Revenue 2015-2026
    • 2.1.2 Global H1N1 Vaccines Sales 2015-2026
  • 2.2 Global H1N1 Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global H1N1 Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global H1N1 Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global H1N1 Vaccines Competitor Landscape by Players

  • 3.1 H1N1 Vaccines Sales by Manufacturers
    • 3.1.1 H1N1 Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 H1N1 Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 H1N1 Vaccines Revenue by Manufacturers
    • 3.2.1 H1N1 Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 H1N1 Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global H1N1 Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by H1N1 Vaccines Revenue in 2019
    • 3.2.5 Global H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 H1N1 Vaccines Price by Manufacturers
  • 3.4 H1N1 Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 H1N1 Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers H1N1 Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into H1N1 Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global H1N1 Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global H1N1 Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global H1N1 Vaccines Revenue by Type (2015-2020)
    • 4.1.3 H1N1 Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global H1N1 Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global H1N1 Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global H1N1 Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 H1N1 Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global H1N1 Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global H1N1 Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global H1N1 Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global H1N1 Vaccines Revenue by Application (2015-2020)
    • 5.1.3 H1N1 Vaccines Price by Application (2015-2020)
  • 5.2 H1N1 Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global H1N1 Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global H1N1 Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global H1N1 Vaccines Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America H1N1 Vaccines by Country
    • 6.1.1 North America H1N1 Vaccines Sales by Country
    • 6.1.2 North America H1N1 Vaccines Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America H1N1 Vaccines Market Facts & Figures by Type
  • 6.3 North America H1N1 Vaccines Market Facts & Figures by Application

7 Europe

  • 7.1 Europe H1N1 Vaccines by Country
    • 7.1.1 Europe H1N1 Vaccines Sales by Country
    • 7.1.2 Europe H1N1 Vaccines Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe H1N1 Vaccines Market Facts & Figures by Type
  • 7.3 Europe H1N1 Vaccines Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific H1N1 Vaccines by Region
    • 8.1.1 Asia Pacific H1N1 Vaccines Sales by Region
    • 8.1.2 Asia Pacific H1N1 Vaccines Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific H1N1 Vaccines Market Facts & Figures by Type
  • 8.3 Asia Pacific H1N1 Vaccines Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America H1N1 Vaccines by Country
    • 9.1.1 Latin America H1N1 Vaccines Sales by Country
    • 9.1.2 Latin America H1N1 Vaccines Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America H1N1 Vaccines Market Facts & Figures by Type
  • 9.3 Central & South America H1N1 Vaccines Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa H1N1 Vaccines by Country
    • 10.1.1 Middle East and Africa H1N1 Vaccines Sales by Country
    • 10.1.2 Middle East and Africa H1N1 Vaccines Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa H1N1 Vaccines Market Facts & Figures by Type
  • 10.3 Middle East and Africa H1N1 Vaccines Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Abbott
    • 11.1.1 Abbott Corporation Information
    • 11.1.2 Abbott Description and Business Overview
    • 11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbott H1N1 Vaccines Products Offered
    • 11.1.5 Abbott Related Developments
  • 11.2 Baxter International
    • 11.2.1 Baxter International Corporation Information
    • 11.2.2 Baxter International Description and Business Overview
    • 11.2.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Baxter International H1N1 Vaccines Products Offered
    • 11.2.5 Baxter International Related Developments
  • 11.3 Sanofi
    • 11.3.1 Sanofi Corporation Information
    • 11.3.2 Sanofi Description and Business Overview
    • 11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Sanofi H1N1 Vaccines Products Offered
    • 11.3.5 Sanofi Related Developments
  • 11.4 GSK
    • 11.4.1 GSK Corporation Information
    • 11.4.2 GSK Description and Business Overview
    • 11.4.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 GSK H1N1 Vaccines Products Offered
    • 11.4.5 GSK Related Developments
  • 11.5 Pfizer
    • 11.5.1 Pfizer Corporation Information
    • 11.5.2 Pfizer Description and Business Overview
    • 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Pfizer H1N1 Vaccines Products Offered
    • 11.5.5 Pfizer Related Developments
  • 11.6 Mitsubishi Tanabe Pharma
    • 11.6.1 Mitsubishi Tanabe Pharma Corporation Information
    • 11.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
    • 11.6.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Products Offered
    • 11.6.5 Mitsubishi Tanabe Pharma Related Developments
  • 11.7 Hualan Biological Engineering
    • 11.7.1 Hualan Biological Engineering Corporation Information
    • 11.7.2 Hualan Biological Engineering Description and Business Overview
    • 11.7.3 Hualan Biological Engineering Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Hualan Biological Engineering H1N1 Vaccines Products Offered
    • 11.7.5 Hualan Biological Engineering Related Developments
  • 11.8 Cipla
    • 11.8.1 Cipla Corporation Information
    • 11.8.2 Cipla Description and Business Overview
    • 11.8.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Cipla H1N1 Vaccines Products Offered
    • 11.8.5 Cipla Related Developments
  • 11.9 Merck
    • 11.9.1 Merck Corporation Information
    • 11.9.2 Merck Description and Business Overview
    • 11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Merck H1N1 Vaccines Products Offered
    • 11.9.5 Merck Related Developments
  • 11.10 Sinovac Biotech
    • 11.10.1 Sinovac Biotech Corporation Information
    • 11.10.2 Sinovac Biotech Description and Business Overview
    • 11.10.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Sinovac Biotech H1N1 Vaccines Products Offered
    • 11.10.5 Sinovac Biotech Related Developments
  • 11.1 Abbott
    • 11.1.1 Abbott Corporation Information
    • 11.1.2 Abbott Description and Business Overview
    • 11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbott H1N1 Vaccines Products Offered
    • 11.1.5 Abbott Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 H1N1 Vaccines Market Estimates and Projections by Region
    • 12.1.1 Global H1N1 Vaccines Sales Forecast by Regions 2021-2026
    • 12.1.2 Global H1N1 Vaccines Revenue Forecast by Regions 2021-2026
  • 12.2 North America H1N1 Vaccines Market Size Forecast (2021-2026)
    • 12.2.1 North America: H1N1 Vaccines Sales Forecast (2021-2026)
    • 12.2.2 North America: H1N1 Vaccines Revenue Forecast (2021-2026)
    • 12.2.3 North America: H1N1 Vaccines Market Size Forecast by Country (2021-2026)
  • 12.3 Europe H1N1 Vaccines Market Size Forecast (2021-2026)
    • 12.3.1 Europe: H1N1 Vaccines Sales Forecast (2021-2026)
    • 12.3.2 Europe: H1N1 Vaccines Revenue Forecast (2021-2026)
    • 12.3.3 Europe: H1N1 Vaccines Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific H1N1 Vaccines Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: H1N1 Vaccines Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: H1N1 Vaccines Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: H1N1 Vaccines Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America H1N1 Vaccines Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: H1N1 Vaccines Sales Forecast (2021-2026)
    • 12.5.2 Latin America: H1N1 Vaccines Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: H1N1 Vaccines Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa H1N1 Vaccines Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: H1N1 Vaccines Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: H1N1 Vaccines Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: H1N1 Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key H1N1 Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 H1N1 Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    H1N1 Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global H1N1 Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the H1N1 Vaccines market is segmented into
    Intramuscular Vaccines
    Intranasal Vaccines
    Intradermal Vaccines

    Segment by Application, the H1N1 Vaccines market is segmented into
    Influenza
    Meningococcal
    Cervical Cancer
    Pneumococcal
    Hepatitis
    Measles
    Mumps
    Rubella
    Others

    Regional and Country-level Analysis
    The H1N1 Vaccines market is analysed and market size information is provided by regions (countries).
    The key regions covered in the H1N1 Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and H1N1 Vaccines Market Share Analysis
    H1N1 Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in H1N1 Vaccines business, the date to enter into the H1N1 Vaccines market, H1N1 Vaccines product introduction, recent developments, etc.

    The major vendors covered:
    Abbott
    Baxter International
    Sanofi
    GSK
    Pfizer
    Mitsubishi Tanabe Pharma
    Hualan Biological Engineering
    Cipla
    Merck
    Sinovac Biotech

    Buy now